Chlamydia pneumoniae infection and Alzheimer's disease: A connection to remember?

Medical Microbiology and Immunology

Volumn 199, Issue 4, 2010, Pages 283-289

  Shima, Kensuke ^a   Kuhlenbäumer, Gregor ^b   Rupp, Jan ^a,c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Medical Clinic III   (Germany)

Author keywords

Alzheimer's disease; Chlamydia pneumoniae; Pathogenesis

Indexed keywords

AMYLOID BETA PROTEIN; BACTERIAL DNA; DOXYCYCLINE; INTERCELLULAR ADHESION MOLECULE 1; RIFAMPICIN; VASCULAR CELL ADHESION MOLECULE 1;

ALZHEIMER DISEASE; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; BLOOD BRAIN BARRIER; BRAIN INFECTION; CELL MIGRATION; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; COGNITION; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; MONOCYTE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION;

ALZHEIMER DISEASE; BRAIN; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS;

EID: 78449282143     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-010-0162-1     Document Type: Review

References (59)

1. Fratiglioni L, von Strauss E, Qiu C (2008) Epidemiology of the dementias of old age. In: Jacoby R, Oppenheimer C, Dening T, Thomas A (eds) The Oxford textbook of old age psychiatry. Oxford University press, New York, pp 391-406
2. CP Ferri M Prince C Brayne H Brodaty L Fratiglioni M Ganguli K Hall K Hasegawa H Hendrie Y Huang A Jorm C Mathers PR Menezes E Rimmer M Scazufca 2005 Global prevalence of dementia: a Delphi consensus study Lancet 366 2112 2117 10.1016/S0140-6736(05)67889-0 16360788
3. R Brookmeyer E Johnson K Ziegler-Graham HM Arrighi 2007 Forecasting the global burden of Alzheimer's disease Alzheimers Dement 3 186 191 10.1016/j.jalz.2007.04.381 19595937
4. L Bertram RE Tanzi 2008 Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat Rev Neurosci 9 768 778 1:CAS:528:DC%2BD1cXhtFeit7fL 10.1038/nrn2494 18802446
5. EH Corder AM Saunders WJ Strittmatter DE Schmechel PC Gaskell GW Small AD Roses JL Haines MA Pericak-Vance 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 921 923 1:CAS:528:DyaK3sXmtVWjur8%3D 10.1126/science.8346443 8346443
6. WJ Strittmatter AM Saunders D Schmechel M Pericak-Vance J Enghild GS Salvesen AD Roses 1993 Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc Natl Acad Sci U S A 90 1977 1981 1:CAS:528:DyaK3sXhs1Klsrs%3D 10.1073/pnas.90.5.1977 8446617
7. MS Parihar T Hemnani 2004 Alzheimer's disease pathogenesis and therapeutic interventions J Clin Neurosci 11 456 467 1:CAS:528: DC%2BD2cXks1eksL0%3D 10.1016/j.jocn.2003.12.007 15177383
8. K Honjo R van Reekum NP Verhoeff 2009 Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 5 348 360 10.1016/j.jalz.2008.12.001 19560105
9. WP Koh MB Taylor K Hughes SK Chew CW Fong MC Phoon KL Kang VT Chow 2002 Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore Int J Epidemiol 31 1001 1007 10.1093/ije/31.5.1001 12435775
10. F Blasi P Tarsia S Aliberti 2009 Chlamydophila pneumoniae Clin Microbiol Infect 15 29 35 1:CAS:528:DC%2BD1MXjslanu7o%3D 10.1111/j.1469-0691.2008.02130.x 19220337
11. N Miyashita A Matsumoto Y Kubota M Nakajima Y Niki T Matsushima 1996 Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis Microbiol Immunol 40 547 552 1:CAS:528: DyaK28XlvFWqu7o%3D 8887348
12. MR Hammerschlag K Chirgwin PM Roblin M Gelling W Dumornay L Mandel P Smith J Schachter 1992 Persistent infection with Chlamydia pneumoniae following acute respiratory illness Clin Infect Dis 14 178 182 1:STN:280: DyaK383jvFGltw%3D%3D 1571425
13. WL Beatty GI Byrne RP Morrison 1993 Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro Proc Natl Acad Sci U S A 90 3998 4002 1:CAS:528: DyaK3sXktVOju74%3D 10.1073/pnas.90.9.3998 8387206
14. WL Beatty RP Morrison GI Byrne 1995 Reactivation of persistent Chlamydia trachomatis infection in cell culture Infect Immun 63 199 205 1:CAS:528:DyaK2MXisl2kt74%3D 7806358
15. SJ Mehta RD Miller JA Ramirez JT Summersgill 1998 Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism J Infect Dis 177 1326 1331 1:CAS:528:DyaK1cXivFags7s%3D 10.1086/515287 9593020
16. JT Summersgill NN Sahney CA Gaydos TC Quinn JA Ramirez 1995 Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha Infect Immun 63 2801 2803 1:CAS:528: DyaK2MXmsF2itLw%3D 7790105
17. U Dreses-Werringloer I Padubrin B Jurgens-Saathoff AP Hudson H Zeidler L Kohler 2000 Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro Antimicrob Agents Chemother 44 3288 3297 1:CAS:528:DC%2BD3MXhs1Kitrs%3D 10.1128/AAC.44.12.3288-3297.2000 11083629
18. A Matsumoto GP Manire 1970 Electron Microscopic Observations on the Fine Structure of Cell Walls of Chlamydia psittaci J Bacteriol 104 1332 1337 1:STN:280:DC%2BC3cngs1agtQ%3D%3D 16559112
19. A Harper CI Pogson ML Jones JH Pearce 2000 Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation Infect Immun 68 1457 1464 1:CAS:528:DC%2BD3cXhsVKrs7g%3D 10.1128/IAI.68.3.1457-1464.2000 10678960
20. BJ Balin HC Gerard EJ Arking DM Appelt PJ Branigan JT Abrams JA Whittum-Hudson AP Hudson 1998 Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain Med Microbiol Immunol 187 23 42 1:CAS:528:DyaK1cXkvFSgtLs%3D 10.1007/s004300050071 9749980
21. HC Gerard KL Wildt JA Whittum-Hudson Z Lai J Ager AP Hudson 2005 The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype Microb Pathog 39 19 26 1:CAS:528:DC%2BD2MXmvVGisr4%3D 10.1016/j.micpath.2005.05. 002 15998578
22. HC Gerard U Dreses-Werringloer KS Wildt S Deka C Oszust BJ Balin WH Frey EZ Bordayo JA Whittum-Hudson AP Hudson 2006 Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain FEMS Immunol Med Microbiol 48 355 366 1:CAS:528:DC%2BD28Xht1ylsbfK 10.1111/j.1574-695X.2006.00154.x 17052268
23. U Dreses-Werringloer M Bhuiyan Y Zhao HC Gerard JA Whittum-Hudson AP Hudson 2009 Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain Int J Med Microbiol 299 187 201 1:CAS:528:DC%2BD1MXlsFOgs74%3D 10.1016/j.ijmm.2008.07.002 18829386
24. SF Dowell RW Peeling J Boman GM Carlone BS Fields J Guarner MR Hammerschlag LA Jackson CC Kuo M Maass TO Messmer DF Talkington ML Tondella SR Zaki 2001 Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) Clin Infect Dis 33 492 503 1:CAS:528: DC%2BD3MXms1eht7w%3D 10.1086/322632 11462186
25. M Kaufman CA Gaydos S Sriram J Boman ML Tondella HJ Norton 2002 Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results Mult Scler 8 289 294 1:STN:280: DC%2BD38vht1Gmug%3D%3D 10.1191/1352458502ms815oa 12166498
26. Y Ochiai H Fukushi C Yan T Yamaguchi K Hirai 2000 Comparative analysis of the putative amino acid sequences of chlamydial heat shock protein 60 and Escherichia coli GroEL J Vet Med Sci 62 941 945 1:CAS:528:DC%2BD3cXns1Grtrg%3D 10.1292/jvms.62.941 11039588
27. ML Tondella G Galagoda CA Gaydos J Boman 2003 Is Chlamydia pneumoniae present in cerebrospinal fluid of multiple sclerosis patients? Clin Diagn Lab Immunol 10 977 978 12965938
28. MM Ieven VY Hoymans 2005 Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence J Clin Microbiol 43 19 24 10.1128/JCM.43.1.19-24.2005 15634945
29. D Nochlin CM Shaw LA Campbell CC Kuo 1999 Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease Neurology 53 1888 1:STN:280:DC%2BD3c%2FisFWktA%3D%3D 10563652
30. J Gieffers E Reusche W Solbach M Maass 2000 Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients J Clin Microbiol 38 881 882 1:STN:280:DC%2BD3c7it1CrsQ%3D%3D 10655406
31. RH Ring JM Lyons 2000 Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain J Clin Microbiol 38 2591 2594 1:STN:280: DC%2BD3cvitFSruw%3D%3D 10878049
32. GS Taylor IB Vipond ID Paul S Matthews GK Wilcock EO Caul 2002 Failure to correlate C. pneumoniae with late onset Alzheimer's disease Neurology 59 142 143 1:STN:280:DC%2BD38zmtVOntA%3D%3D 12105327
33. MA Wozniak A Cookson GK Wilcock RF Itzhaki 2003 Absence of Chlamydia pneumoniae in brain of vascular dementia patients Neurobiol Aging 24 761 765 10.1016/S0197-4580(02)00236-1 12927758
34. MB Loeb DW Molloy M Smieja T Standish CH Goldsmith J Mahony S Smith M Borrie E Decoteau W Davidson A McDougall J Gnarpe M O'DONNell M Chernesky 2004 A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease J Am Geriatr Soc 52 381 387 10.1111/j.1532-5415.2004.52109.x 14962152
35. B Paradowski M Jaremko T Dobosz J Leszek L Noga 2007 Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia J Neurol 254 154 159 1:CAS:528:DC%2BD2sXlsVCnsb0%3D 10.1007/s00415-006-0298-5 17318713
36. MT Gilbert T Haselkorn M Bunce JJ Sanchez SB Lucas LD Jewell ME Van M Worobey 2007 The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when? PLoS One 2 e537 10.1371/journal.pone. 0000537 17579711
37. I Ferrer J Armstrong S Capellari P Parchi T Arzberger J Bell H Budka T Strobel G Giaccone G Rossi N Bogdanovic P Fakai A Schmitt P Riederers S Al-Sarraj R Ravid H Kretzschmar 2007 Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study Brain Pathol 17 297 303 1:CAS:528:DC%2BD2sXptFOlurg%3D 10.1111/j.1750-3639.2007.00073.x 17465988
38. A Ribeiro-Silva H Zhang SS Jeffrey 2007 RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies BMC Mol Biol 8 118 10.1186/1471-2199-8-118 18154675
39. S Kumar MR Hammerschlag 2007 Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods Clin Infect Dis 44 568 576 10.1086/511076 17243062
40. S Sriram W Mitchell C Stratton 1998 Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS Neurology 50 571 572 1:STN:280:DyaK1c7ksFCjsA%3D%3D 9484408
41. S Sriram CW Stratton S Yao A Tharp L Ding JD Bannan WM Mitchell 1999 Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis Ann Neurol 46 6 14 1:CAS:528:DyaK1MXksl2itbk%3D 10.1002/1531- 8249(199907)46:1<6::AID-ANA4>3.0.CO;2-M 10401775
42. RH Swanborg JA Whittum-Hudson AP Hudson 2003 Infectious agents and multiple sclerosis-are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 136 1 8 1:CAS:528:DC%2BD3sXhs1ahtLg%3D 10.1016/S0165-5728(02) 00465-4 12620637
43. J Boman MR Hammerschlag 2002 Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies Clin Microbiol Rev 15 1 20 1:CAS:528:DC%2BD38XnsVyqsw%3D%3D 10.1128/CMR.15.1.1- 20.2002 11781264
44. P Apfalter O Assadian F Blasi J Boman CA Gaydos M Kundi A Makristathis M Nehr ML Rotter AM Hirschl 2002 Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols J Clin Microbiol 40 4428 4434 1:CAS:528: DC%2BD38Xps1ygsrg%3D 10.1128/JCM.40.12.4428-4434.2002 12454131
45. MR Hammerschlag 1994 Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae Antimicrob Agents Chemother 38 1873 1878 1:CAS:528:DyaK2cXlvFCksLc%3D 7810992
46. K Siewert J Rupp M Klinger W Solbach J Gieffers 2005 Growth cycle-dependent pharmacodynamics of antichlamydial drugs Antimicrob Agents Chemother 49 1852 1856 1:CAS:528:DC%2BD2MXktFSnt7k%3D 10.1128/AAC.49.5.1852- 1856.2005 15855506
47. A Kutlin PM Roblin MR Hammerschlag 1999 In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model Antimicrob Agents Chemother 43 2268 2272 1:CAS:528:DyaK1MXlvVGrurs%3D 10471577
48. J Gieffers H Fullgraf J Jahn M Klinger K Dalhoff HA Katus W Solbach M Maass 2001 Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment Circulation 103 351 356 1:CAS:528: DC%2BD3MXhtF2ks7k%3D 11157684
49. J Gieffers J Rupp A Gebert W Solbach M Klinger 2004 First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae Antimicrob Agents Chemother 48 1402 1405 1:CAS:528: DC%2BD2cXjtVKqsb4%3D 10.1128/AAC.48.4.1402-1405.2004 15047553
50. IW Fong B Chiu E Viira D Jang MW Fong R Peeling JB Mahony 1999 Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? Clin Diagn Lab Immunol 6 891 894 1:CAS:528:DyaK1MXnvVymsLk%3D 10548582
51. NM Rothstein TC Quinn G Madico CA Gaydos CJ Lowenstein 2001 Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae J Infect Dis 183 232 238 1:CAS:528:DC%2BD3MXmsFGkug%3D%3D 10.1086/317941 11120929
52. J Gieffers G van Zandbergen J Rupp F Sayk S Kruger S Ehlers W Solbach M Maass 2004 Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature Eur Respir J 23 506 510 1:STN:280:DC%2BD2c7ovVemsQ%3D%3D 10.1183/09031936.04.00093304 15083745
53. A Macintyre R Abramov CJ Hammond AP Hudson EJ Arking CS Little DM Appelt BJ Balin 2003 Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells J Neurosci Res 71 740 750 1:CAS:528:DC%2BD3sXitFWlsbc%3D 10.1002/jnr.10519 12584732
54. CS Little CJ Hammond A Macintyre BJ Balin DM Appelt 2004 Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice Neurobiol Aging 25 419 429 1:CAS:528:DC%2BD2cXhvVyhtr0%3D 10.1016/S0197-4580(03) 00127-1 15013562
55. CS Little A Bowe R Lin J Litsky RM Fogel BJ Balin KL Fresa-Dillon 2005 Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice Infect Immun 73 1723 1734 1:CAS:528:DC%2BD2MXit12msb4%3D 10.1128/IAI.73.3.1723-1734.2005 15731073
56. G Zuliani M Cavalieri M Galvani A Passaro MR Munari C Bosi A Zurlo R Fellin 2008 Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia J Neurol Sci 272 164 170 1:CAS:528:DC%2BD1cXpt1Kitbk%3D 10.1016/j.jns.2008.05.020 18597785
57. T Wyss-Coray 2006 Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12 1005 1015 1:CAS:528: DC%2BD28XptFClurs%3D 16960575
58. DM Appelt MR Roupas DS Way MG Bell EV Albert CJ Hammond BJ Balin 2008 Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae BMC Neurosci 9 13 10.1186/1471-2202-9-13 18218130
59. T Rattei S Ott M Gutacker J Rupp M Maass S Schreiber W Solbach T Wirth J Gieffers 2007 Genetic diversity of the obligate intracellular bacterium Chlamydophila pneumoniae by genome-wide analysis of single nucleotide polymorphisms: evidence for highly clonal population structure BMC Genomics 8 355 10.1186/1471-2164-8-355 17916241